Dy, Alane Blythe C.
Langlais, Paul R.
Barker, Natalie K.
Addison, Kenneth J.
Tanyaratsrisakul, Sasipa
Boitano, Scott
Christenson, Stephanie A.
Kraft, Monica
Meyers, Deborah
Bleecker, Eugene R.
Li, Xingnan
Ledford, Julie G.
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (HL-125602)
Article History
Received: 17 August 2021
Accepted: 19 November 2021
First Online: 3 December 2021
Competing interests
: Drs. Ledford and Kraft are co-founders of RaeSedo LLC, a company to develop novel peptidomimetic based therapeutics derived from an active area of SP-A. However, no SP-A derived therapeutics were used in the work presented in this manuscript. All other co-authors have nothing to disclose.